Betamethasone Explained

Watchedfields:changed
Verifiedrevid:459977512
Tradename:Celestone, Eleuphrat, others
Dailymedid:Betamethasone
Pregnancy Au:C
Pregnancy Au Comment:[1]
Routes Of Administration:By mouth, topical, intramuscular
Atc Prefix:A07
Atc Suffix:EA04
Atc Supplemental:
Legal Au:S4
Legal Uk:POM
Legal Uk Comment:[2]
Legal Us:Rx-only
Legal Status:Rx-only
Metabolism:Liver CYP3A4
Elimination Half-Life:36-54 hours
Excretion:Kidney (in urine)
Cas Number:378-44-9
Pubchem:9782
Iuphar Ligand:7061
Drugbank:DB00443
Chemspiderid:9399
Unii:9842X06Q6M
Kegg:D00244
Chebi:3077
Chembl:632
Iupac Name:(8S,9R,10S,11S,13S,14S,16S,17R)-9-Fluoro- 11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl- 6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro- 3H-cyclopenta[''a'']phenanthren-3-one
C:22
H:29
F:1
O:5
Smiles:O=C(CO)[C@]3(O)[C@]2(C[C@H](O)[C@]4(F)[C@@]/1(\C(=C/C(=O)\C=C\1)CC[C@H]4[C@@H]2C[C@@H]3C)C)C
Stdinchi:1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1
Stdinchikey:UREBDLICKHMUKA-DVTGEIKXSA-N

Betamethasone is a steroid medication.[3] It is used for a number of diseases including rheumatic disorders such as rheumatoid arthritis and systemic lupus erythematosus, skin diseases such as dermatitis and psoriasis, allergic conditions such as asthma and angioedema, preterm labor to speed the development of the baby's lungs, Crohn's disease, cancers such as leukemia, and along with fludrocortisone for adrenocortical insufficiency, among others.[3] It can be taken by mouth, injected into a muscle, or applied to the skin, typically in cream, lotion, or liquid forms.[3] [4]

Serious side effects include an increased risk of infection, muscle weakness, severe allergic reactions, and psychosis.[3] Long-term use may cause adrenal insufficiency.[3] Stopping the medication suddenly following long-term use may be dangerous.[3] The cream commonly results in increased hair growth and skin irritation.[4] Betamethasone belongs to the glucocorticoid class of medication.[3] It is a stereoisomer of dexamethasone, the two compounds differing only in the spatial configuration of the methyl group at position 16 (see steroid nomenclature).[5]

Betamethasone was patented in 1958, and approved for medical use in the United States in 1961.[3] [6] The cream and ointment are on the World Health Organization's List of Essential Medicines.[7] It is available as a generic medication.[3] In 2021, it was the 251st most commonly prescribed medication in the United States, with more than 1million prescriptions.[8] [9]

Medical uses

Betamethasone is a corticosteroid that is available as a pill, by injection, and as an ointment, cream, lotion, gel, or aerosol (spray) for the skin, and a foam for the scalp.[10] When given by injection, anti-inflammatory effects begin in around two hours and last for seven days.[3]

It is used as a topical cream to relieve skin irritation, such as itching and flaking from eczema. It is used as a treatment for local psoriasis, as betamethasone dipropionate and salicylic acid, or as the combination calcipotriol/betamethasone dipropionate. Betamethasone sodium phosphate is used orally and via injection with the same indications as other steroids. Many betamethasone-based pharmaceuticals include the steroid as the valerate ester.

In a randomized controlled trial betamethasone was shown to reduce some of the ataxia (poor coordination) symptoms associated with ataxia telangiectasia (A-T) by 28-31%.[11]

Betamethasone is also used to stimulate fetal lung maturation in order to prevent infant respiratory distress syndrome (IRDS) and to decrease the incidence and mortality from intracranial hemorrhage in premature infants.

A cream with 0.05% betamethasone appears effective in treating phimosis in boys,[12] and often averts the need for circumcision.[13] [14] [15] It has replaced circumcision as the preferred treatment method for some physicians in the British National Health Service.[16] [17]

Side effects

Prolonged use of this medicine on extensive areas of skin, broken or raw skin, skin folds, or underneath airtight dressings may on rare occasions result in enough corticosteroid being absorbed to have side effects on other parts of the body; for example, by causing a decrease in the production of natural hormones by the adrenal glands.

Betamethasone is also used prior to delivery of a preterm baby to help prepare the lungs for breathing. However, because betamethasone crosses the placenta, which is required for its beneficial effects, it may also be associated with complications, such as hypoglycemia and leukocytosis in newborns exposed in utero.

When injected into the epidural space or the spine, it may cause serious side effects like loss of vision, stroke, and paralysis.[19]

Forms

Betamethasone is available in a number of compound forms: betamethasone dipropionate (branded as Diprosone, Diprolene, Celestamine, Procort (in Pakistan), and others), betamethasone sodium phosphate (branded as Bentelan in Italy) and betamethasone valerate (branded as Audavate, Betnovate, Celestone, Fucibet, and others). In the United States and Canada, betamethasone is mixed with clotrimazole and sold as Lotrisone and Lotriderm. It is also available in combination with salicylic acid (branded as Diprosalic) for using in psoriatic skin conditions. In some countries, it is also sold mixed with both clotrimazole and gentamicin to add an antibacterial agent to the mix.

Betamethasone sodium phosphate mixed with betamethasone acetate is available in the United States as Celestone Soluspan.[20]

See also

Notes and References

  1. Web site: Betamethasone Use During Pregnancy . Drugs.com . 30 December 2019 . 29 March 2020.
  2. Web site: Betamethasone 500 microgram Soluble Tablets - Summary of Product Characteristics (SmPC) . (emc) . 5 April 2018 . 29 March 2020.
  3. Web site: Betamethasone. The American Society of Health-System Pharmacists. 2 December 2015. live. https://web.archive.org/web/20151208152909/http://www.drugs.com/monograph/betamethasone.html. 8 December 2015.
  4. Web site: Betamethasone topical. The American Society of Health-System Pharmacists. 2 December 2015. live. https://web.archive.org/web/20151208025858/https://www.drugs.com/monograph/betamethasone-topical.html. 8 December 2015.
  5. Antignac JP, Le Bizec B, Monteau F, Andre F . Differentiation of betamethasone and dexamethasone using liquid chromatography/positive electrospray tandem mass spectrometry and multivariate statistical analysis . Journal of Mass Spectrometry . 37 . 1 . 69–75 . January 2002 . 11813313 . 10.1002/jms.260 . 2002JMSp...37...69A .
  6. Book: Fischer J, Ganellin CR . Analogue-based Drug Discovery . 2006 . John Wiley & Sons . 9783527607495 . 485 .
  7. Book: ((World Health Organization)) . World Health Organization model list of essential medicines: 21st list 2019 . 2019 . 10665/325771 . World Health Organization . World Health Organization . Geneva . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO . free .
  8. Web site: The Top 300 of 2021 . ClinCalc . 14 January 2024 . 15 January 2024 . https://web.archive.org/web/20240115223848/https://clincalc.com/DrugStats/Top300Drugs.aspx . live .
  9. Web site: Betamethasone - Drug Usage Statistics . ClinCalc . 14 January 2024.
  10. Web site: Betamethasone Topical . MedlinePlus . 19 March 2020 . 29 March 2020 .
  11. Zannolli R, Buoni S, Betti G, Salvucci S, Plebani A, Soresina A, Pietrogrande MC, Martino S, Leuzzi V, Finocchi A, Micheli R, Rossi LN, Brusco A, Misiani F, Fois A, Hayek J, Kelly C, Chessa L . 6 . A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia . Movement Disorders . 27 . 10 . 1312–1316 . September 2012 . 22927201 . 10.1002/mds.25126 . 23696748 .
  12. Moreno G, Corbalán J, Peñaloza B, Pantoja T . Topical corticosteroids for treating phimosis in boys . The Cochrane Database of Systematic Reviews . 9 . 9 . CD008973 . September 2014 . 25180668 . 10.1002/14651858.CD008973.pub2 . 10765470 .
  13. Van Howe RS . Cost-effective treatment of phimosis . Pediatrics . 102 . 4 . E43 . October 1998 . 9755280 . 10.1542/peds.102.4.e43 . live . free . https://web.archive.org/web/20090819103253/http://pediatrics.aappublications.org/cgi/content/full/102/4/e43 . 19 August 2009 . A review of estimated costs and complications of 3 phimosis treatments.
  14. Esposito C, Centonze A, Alicchio F, Savanelli A, Settimi A . Topical steroid application versus circumcision in pediatric patients with phimosis: a prospective randomized placebo controlled clinical trial . World Journal of Urology . 26 . 2 . 187–190 . April 2008 . 18157674 . 10.1007/s00345-007-0231-2 . Springer Science and Business Media LLC . 8922151 .
  15. Zampieri N, Corroppolo M, Zuin V, Bianchi S, Camoglio FS . Phimosis and topical steroids: new clinical findings . Pediatric Surgery International . 23 . 4 . 331–335 . April 2007 . 17308904 . 10.1007/s00383-007-1878-x . 22849471 .
  16. Berdeu D, Sauze L, Ha-Vinh P, Blum-Boisgard C . Cost-effectiveness analysis of treatments for phimosis: a comparison of surgical and medicinal approaches and their economic effect . BJU International . 87 . 3 . 239–244 . February 2001 . 11167650 . 10.1046/j.1464-410x.2001.02033.x . 2161551 . free .
  17. Chu CC, Chen KC, Diau GY . Topical steroid treatment of phimosis in boys . The Journal of Urology . 162 . 3 Pt 1 . 861–863 . September 1999 . 10458396 . 10.1097/00005392-199909010-00078 .
  18. Web site: betamethasone . F.A. Davis . 2017 . 7 March 2017 . live . https://web.archive.org/web/20170908175627/https://davisplus.fadavis.com/3976/MedDeck/pdf/betamethasonesystemic.pdf . 8 September 2017 .
  19. Web site: FDA Drug Safety Communication: FDA requires label changes to warn of rare but serious neurologic problems after epidural corticosteroid injections for pain. FDA. 15 August 2016. 23 April 2014. live. https://web.archive.org/web/20160811081058/https://www.fda.gov/Drugs/DrugSafety/ucm394280.htm. 11 August 2016.
  20. Web site: Celestone Soluspan- betamethasone acetate and betamethasone sodium phosphate injection, suspension . DailyMed . 18 November 2019 . 29 March 2020.